Toll-like receptors as targets for inflammation, development and repair in the central nervous system

Current Opinion in Investigational Drugs

Volumn 8, Issue 1, 2007, Pages 60-65

  Van Noort, Johannes M ^a  

^a TNO   (Netherlands)

Author keywords

Astrocyte; CNS; Inflammation; Microglia; Tissue repair; Toll like receptor

Indexed keywords

DOUBLE STRANDED RNA; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; ZYMOSAN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ASTROCYTE; BRAIN PROTECTION; CELL TYPE; CENTRAL NERVOUS SYSTEM; HOST RESISTANCE; HUMAN; INFORMATION PROCESSING; KNOCKOUT MOUSE; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; INFLAMMATION; TOLL-LIKE RECEPTORS;

EID: 33947310249     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature (1997) 388(6640):394-397. •• The first description of TLRs as pattern recognition receptors for microbial ligands.
2. Pasare C, Medzhitov R: Toll-like receptors: Linking innate and adaptive immunity. Adv Exp Med Biol (2005) 560:11-18.
3. Kaishio T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol (2006) 117(5):979-987.
4. Kielian T: Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res (2006) 83(5):711-730.
5. Morisato D, Anderson KV: Signaling pathways that establish the dorsal-ventral pattern of the Drosophila embryo. Annu Rev Genet (1995) 29:371-399.
6. Jiang D, Jiang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ et al: Regulation of lung injury and repair by toll like receptors and hyaluronan. Nat Med (2005) 11(11):1173-1179. •• This paper reveals that in response to endogenous agonists, the same TLR can be involved either in mediating injury or promoting tissue repair.
7. Kariko K, Ni H, Capodici J, Lamphier M, Weisman D: mRNA is an endogenous ligand for toll-like receptor 3. J Biol Chem (2004) 279(13):12542-12550. • This paper identifies mRNA as an endogenous double-stranded RNA agonist for TLR3.
8. Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, van Noort JM: Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia (2006) 53(7):688-695. •• Evidence is presented that human adult astrocytes preferentially express TLR3 in response to inflammatory signals and that TLR3-mediated activation of astrocytes subsequently triggers a beneficial tissue repair response.
9. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A: The repertoire for pattern recognition of pathogens by the innate system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA (2000) 97(25):13766-13771.
10. Bsibsi M, Ravid R, Gveric D, van Noort JM: Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 61(11):1013-1021.
11. De Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, Bates EE, Caux C: Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem (2005) 280(46):38133-38145. • This paper describes the effect of the subcellular microenvironment on TLR signaling.
12. O'Neill LA: How toll-like receptors signal: What we know and what we don't know. Curr Opin Immunol (2006) 18(1):3-9.
13. Rehli M: Of mice and men: Species variations of toll-like receptor expression. Trends Immunol (2002) 23(8):375-378.
14. Kagan JC, Medzhitov R: Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell (2006) 125(5):943-955.
15. Bowman CC, Rasley A, Transguch SL, Marriott I: Cultured astrocytes express Toll-like receptors for bacterial products. Glia (2003) 43(3):281-291.
16. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E: Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol (2005) 159(1-2):12-19.
17. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol (2005) 175(7):4320-4330.
18. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD: Differential activation of astrocytes by innate and adaptive immune stimuli. Glia (2005) 49(3):360-374.
19. Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol (2004) 173(6):3916-3924.
20. McKimmie CS, Fazakerley JK: In response to pathogens, glial cells dynamically and differentially regulate toll-like receptor gene expression. J Neuroimmunol (2005) 169(1-2):116-125.
21. McKimmie CS, Johnson N, Fooks AR, Fazakerley JK: Viruses selectively upregulate toll-like receptors in the central nervous system. Biochem Biophys Res Commun (2005) 336(3):925-933.
22. Jackson AC, Rossiter JP, Lafon M: Expression of toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J Neurovirol (2006) 12(3):229-234.
23. Préhaud C, Mégret F, Lafage M, Lafon M: Virus infection switches TLR-3-positive human neurons to become strong producers of β interferon. J Virol (2005) 79(20):12893-12904. • This is the first report to claim expression of a TLR in human neurons.
24. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lü J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T: Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol (2006) 175(2):209-215. •• This paper describes the developmental role of TLR8 in neuronal development.
25. Strober W, Murray PJ, Kitani A, Watanabe T: Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol (2006) 6(1):9-20.
26. Esen N, Kielian T: Central role for MyD88 in the response of microglia to pathogen-associated molecular patterns. J Immunol (2006) 176(11):6802-6811.
27. Konat GW, Kielian T, Marriott I: The role of toll-like receptors in CNS response to microbial challenge. J Neurochem (2006) 99(1):1-12.
28. Koedel U, Angele B, Rupprecht T, Wagner H, Roggenkamp A, Pfister HW, Kirschning CJ: Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol (2003) 170(1):438-444.
29. Koedel U, Rupprecht, Angele B, Heesemann J, Wagner H, Pfister H-W, Kirschning CJ: MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain (2004) 127(6):1437-1445.
30. Kielian T, Esen N, Bearden ED: Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia (2005) 49(4):567-576.
31. Esen N, Tanga FY, DeLeo JA, Kielian T: Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem (2004) 88(3):746-758.
32. Lehnardt S, Henneke P, Lien E, Kasper DL, Volpe JJ, Bechmann I, Nitsch R, Weber JR, Golenbock DT, Vartanian T: A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol (2006) 177(1):583-592.
33. Herrmann I, Kellert M, Schmidt H, Mildner A, Hanisch UK, Bruck W, Prinz M, Nau R: Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via toll-like receptor 2. Infect Immun (2006) 74(8):4841-4848.
34. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA (2004) 101(5):1315-1320.
35. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ: Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia (2006) 54(4):297-303. • This study demonstrated that TLR2-mediated activation can contribute to repair processes.
36. Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM: Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide. J Biol Chem (2006) 281(6):3651-3659.
37. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K: Role of toll-like receptor signaling in Aβ uptake and clearance. Brain (2006) 129(11):3006-3019. ••This study provided in vivo evidence for the beneficial effects of microglial TLR activation in an animal model of AD.
38. So EY, Kang MH, Kim BS: Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the toll-like receptor 3. Glia (2006) 53(8):858-867.
39. Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RA, Oldstone MBA: Does toll-like receptor 3 play a biological role in virus infections? Virology (2004) 322(2):231-238.
40. Wang T, Town T, Alexopoulou L, Anedrson JF, Fikrig E, Flavell RA: Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med (2004) 10(12):1366-1373.
41. Elco CP, Guenther JM, Williams BRG, Sen GC: Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-κB, and interferon but not toll-like receptor 3. J Virol (2005) 79(7):3920-3929.
42. Ebert S, Gerber J, Bader S, Muhlhauser F, Brechtel K, Mitchell TJ, Nau R: Dose-dependent activation of microglial cells by toll-like receptor agonists alone and in combination. J Neuroimmmunol (2005) 159(1-2):87-96.
43. Town T, Jeng D, Alexopoulou L, Tan J, Falvell RA: Microglia recognize double-stranded RNA via TLR3. J Immunol (2006) 176(6):3804- 3812.
44. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA (2003) 100(14):8514-8519.
45. Eklind S, Mallard C, Leverin AL, Gilland E, Blomgren K, Mattsby-Baltzer I, Hagberg H: Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci (2001) 13(6):1101- 1106.
46. Coumans AB, Middelanis JS, Garnier Y, Vaihinger H-M, Leib SL, von Duering MU, Hasaart TH, Jensen A, Berger R: Intracisternal application of endotoxin enhances the susceptibility to subsequent hypoxic-ischemic brain damage in neonatal rats. Pediatr Res (2003) 53(5):770-775.
47. Chakravarty S, Herkenham M: Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines. J Neurosci (2005) 25(7):1788-1796.
48. Waldner H, Collins M, Kuchroo VK: Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest (2004) 113(7):990-997.
49. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, Kubes P: TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol (2004) 173(11):7070-7077.
50. Tanga FY, Nutile-McMenemy N, DeLeo JA: The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA (2005) 102(16):5856-5861.
51. Laflamme N, Echchannaoui H, Landmann R, Rivest S: Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria. Eur J Immunol (2003) 33(4):1127-1138. • This paper describes a functional cooperation between different TLR family members in the CNS.
52. Jung DY, Lee H, Jung B-Y, Ock J, Lee M-S, Lee W-H, Suk K: TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: A critical role of IFN-β as a decision maker. J Immunol (2005) 174(10):6467-6476.
53. Dalpke AH, Schaefer MK-H, Frey M, Zimmermann S, Tebbe J, Weihe E, Heeg K: Immunostimulatory CpG-DNA activates murine microglia. J Immunol (2002) 168(10):4854-4863.
54. Iliev AI, Stringaris AK, Nau R, Neumann H: Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J (2004) 18(2):412-414.
55. Iribarren P, Chen K, Hu J, Gong W, Cho EH, Lockett S, Uranchimeg B, Wang JM: CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1-42 peptide by upregulating the expression of the G-protein-coupled receptor mFPR2. FASEB J (2005) 19(14):2032- 2034.
56. Pedras-Vasconcelos JA, Goucher D, Puig M, Tonelli LH, Wang V, Ito S, Verthelyi D: CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus. J Immunol (2006) 176:4940-4949.
57. El Andaloussi A, Sonabend AM, Han Y, Lesniak MS: Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumours. Glia (2006) 54(6):526-535.
58. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ, Rochford CD et al: Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest (2006) 116(2):456-464. •• This paper shows a role of TLR9 in modulating immune functions in the CNS in the absence of infection, suggestive of an endogenous TLR9 agonist in the CNS.
59. 299Gly polymorphism on susceptibility to late-onset Alzheimer's disease. Neurosci Lett (2006) 391(3):147-149.
60. 299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. J Neuroimmunol (2005) 165(1-2):161-165.
61. Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Marculescu R, Lang W, Wagner O, Cheng S, Mannhalter C: Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med (2006) 44(8):918-923.
62. Zhang Z, Trautmann K, Schluesener HJ: Microglia activation in rat spinal cord by systemic injection of TLR3 and TLR7/8 agonists. J Neuroimmunol (2005) 164(1-2):154-160.
63. Su Y, Zhang Z, Trautmann K, Xu S, Schluesener HJ: TLR and NOD2 ligands induce cell proliferation in the rat intact spinal cord. J Neuropathol Exp Neurol (2005) 64(11):991-997. • This study demonstrated that peripheral activation of TLRs can have unsuspected local effects within the CNS.
64. Prins RM, Craft N, Bruhn KW, Khan-Farooqi H, Koya RC, Stripecke R, Miller JF, Liau LM: The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: Relation to central nervous system antitumor immunity. J Immunol (2006) 176(1):157-164.